Cambridge Investment Research Advisors »

Lexicon Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 23k 1.37
2025-06-30 $20k 22k 0.93
2025-03-31 $10k 22k 0.45
2024-12-31 $17k 24k 0.72
2023-09-30 $16k 14k 1.12

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
Citadel Advisors
Sessa Capital IM
Atlantic Trust
Geode Capital Management
Caption Management
Susquehanna International
GSA Capital Partners
Charles Schwab Investment Management
State Street Corporation

View all funds holding Lexicon Pharmaceuticals